Last 12 months
Inside the activity.
0 purchase rows · 93 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 16 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 49 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 08, 2026 Filed Sep 10, 2026 20:31 UTC |
van Grunsven JasperEVP, CP and NPPO
|
GrantCommon Stock | 8,682 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-26-000272 · wk-form4_1789072310.xml · nonDerivative · entry 1 van Grunsven Jasper · CIK 0002154061 · EVP, CP and NPPO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,682 F1 · shares: Restricted stock unit award that vests in installments beginning on 09/08/2027. Read SEC document |
| August 28, 2026 Filed Sep 1, 2026 20:39 UTC |
Ambrose KristenSVP & Chief Accounting Officer
|
GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-26-000267 · wk-form4_1788295172.xml · nonDerivative · entry 1 Ambrose Kristen · CIK 0001856587 · SVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,624 F1 · shares: Restricted stock unit award that vests on 03/01/2029. Read SEC document |
| August 27, 2026 Filed Aug 31, 2026 20:20 UTC |
SACHS BRUCE IDirector
|
GiftCommon Stock | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-26-000261 · wk-form4_1788207608.xml · nonDerivative · entry 1 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,000 Read SEC document |
| July 21, 2026 Filed Jul 23, 2026 20:13 UTC |
Sachdev AmitEVP Chief Patient & Ext Af Off
|
GrantCommon Stock | 8,251 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-26-000251 · wk-form4_1784837586.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · EVP Chief Patient & Ext Af Off 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,512 F1 · shares: Restricted stock unit award that vests on 03/31/2030. Read SEC document |
| July 21, 2026 Filed Jul 23, 2026 20:15 UTC |
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
|
GrantCommon Stock | 8,251 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-26-000253 · wk-form4_1784837739.xml · nonDerivative · entry 1 Tatsis Ourania · CIK 0001789815 · EVP, Chief Reg. & Quality Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,572 F1 · shares: Restricted stock unit award that vests on 03/31/2030. Read SEC document |
| July 15, 2026 Filed Jul 17, 2026 20:05 UTC |
Garber Alan MDirector
|
GrantDeferred Stock Units · Derivative | 31.56 | $475.28 | $14,999.84 |
DisclosureSEC source: 0000875320-26-000247 · wk-form4_1784318742.xml · derivative · entry 1 Garber Alan M · CIK 0001312907 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65.458 Underlying: Common Stock · 31.56 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Garber's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Garber's disability or death. F1 · derivative.exercise_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Garber's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Garber's disability or death. F1 · derivative.expiration_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Garber's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Garber's disability or death. Read SEC document |
| July 15, 2026 Filed Jul 17, 2026 20:06 UTC |
SACHS BRUCE IDirector
|
GrantDeferred Stock Units · Derivative | 99.941 | $475.28 | $47,499.96 |
DisclosureSEC source: 0000875320-26-000249 · wk-form4_1784318797.xml · derivative · entry 1 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,771.807 Underlying: Common Stock · 99.941 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death. F1 · derivative.exercise_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death. F1 · derivative.expiration_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death. Read SEC document |
| July 02, 2026 Filed Jul 7, 2026 20:08 UTC |
McKechnie DuncanEVP, Chief Commercial Officer
|
SaleCommon Stock | 1,541 | $519.00 | $799,779.00 |
DisclosureSEC source: 0000875320-26-000243 · wk-form4_1783454880.xml · nonDerivative · entry 1 McKechnie Duncan · CIK 0002062139 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,001 F1 · kind: Transaction made pursuant to Mr. McKechnie's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025. Read SEC document |
| July 02, 2026 Filed Jul 7, 2026 20:15 UTC |
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
|
SaleCommon Stock | 1,500 | $524.99 | $787,485.00 |
DisclosureSEC source: 0000875320-26-000245 · wk-form4_1783455338.xml · nonDerivative · entry 1 Tatsis Ourania · CIK 0001789815 · EVP, Chief Reg. & Quality Off. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 45,321 F1 · kind: Transaction made pursuant to Dr. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 08/21/2025. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 20:13 UTC |
Liu JoyEVP and Chief Legal Officer
|
SaleCommon Stock | 828 | $502.71 | $416,243.88 |
DisclosureSEC source: 0000875320-26-000241 · wk-form4_1783368787.xml · nonDerivative · entry 1 Liu Joy · CIK 0001847529 · EVP and Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,131 F1 · kind: Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025. Read SEC document |
| June 26, 2026 Filed Jun 30, 2026 20:09 UTC |
Bozic CarmenEVP and CMO
|
SaleCommon Stock | 596 | $482.50 | $287,570.00 |
DisclosureSEC source: 0000875320-26-000239 · wk-form4_1782850180.xml · nonDerivative · entry 1 Bozic Carmen · CIK 0001790029 · EVP and CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,337 F1 · kind: Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025. Read SEC document |
| June 18, 2026 Filed Jun 23, 2026 20:08 UTC |
Bozic CarmenEVP and CMO
|
SaleCommon Stock | 1,020 | $462.17 | $471,413.40 |
DisclosureSEC source: 0000875320-26-000237 · wk-form4_1782245334.xml · nonDerivative · entry 1 Bozic Carmen · CIK 0001790029 · EVP and CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,933 F1 · kind: Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 20:12 UTC |
Bozic CarmenEVP and CMO
|
SaleCommon Stock | 4,062 | $450.00 | $1,827,900.00 |
DisclosureSEC source: 0000875320-26-000235 · wk-form4_1781727153.xml · nonDerivative · entry 1 Bozic Carmen · CIK 0001790029 · EVP and CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,953 F1 · kind: Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 20:24 UTC |
Bozic CarmenEVP and CMO
|
SaleCommon Stock | 1,745 | $450.00 | $785,250.00 |
DisclosureSEC source: 0000875320-26-000233 · wk-form4_1781036661.xml · nonDerivative · entry 1 Bozic Carmen · CIK 0001790029 · EVP and CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,015 F1 · kind: Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:06 UTC |
Liu JoyEVP and Chief Legal Officer
|
SaleCommon Stock | 828 | $439.91 | $364,245.48 |
DisclosureSEC source: 0000875320-26-000230 · wk-form4_1780517191.xml · nonDerivative · entry 1 Liu Joy · CIK 0001847529 · EVP and Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,959 F1 · kind: Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 20:04 UTC |
Bozic CarmenEVP and CMO
|
SaleCommon Stock | 1,974 | $450.00 | $888,300.00 |
DisclosureSEC source: 0000875320-26-000228 · wk-form4_1780430661.xml · nonDerivative · entry 1 Bozic Carmen · CIK 0001790029 · EVP and CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,760 F1 · kind: Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:04 UTC |
Bozic CarmenEVP and CMO
|
SaleCommon Stock | 1,354 | $453.45 | $613,971.30 |
DisclosureSEC source: 0000875320-26-000225 · wk-form4_1779221059.xml · nonDerivative · entry 1 Bozic Carmen · CIK 0001790029 · EVP and CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,734 F1 · kind: Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:05 UTC |
Bunnage Mark E.EVP, Chief Scientific Officer
|
SaleCommon Stock | 33 | $453.45 | $14,963.85 |
DisclosureSEC source: 0000875320-26-000226 · wk-form4_1779221100.xml · nonDerivative · entry 1 Bunnage Mark E. · CIK 0002100735 · EVP, Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,284 F1 · kind: Transaction made pursuant to Dr. Bunnage's company approved trading plan under Rule 10b5-1, which was entered into on 11/26/2025. Read SEC document |
| May 12, 2026 Filed May 14, 2026 20:10 UTC |
Bozic CarmenEVP and CMO
|
SaleCommon Stock | 6,988 | $450.00 | $3,144,600.00 |
DisclosureSEC source: 0000875320-26-000222 · wk-form4_1778789402.xml · nonDerivative · entry 1 Bozic Carmen · CIK 0001790029 · EVP and CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,088 F1 · kind: Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025. Read SEC document |
| May 04, 2026 Filed May 5, 2026 20:51 UTC |
Bhatia Sangeeta N.Director
|
SaleCommon Stock | 318 | $423.73 | $134,746.14 |
DisclosureSEC source: 0000875320-26-000175 · wk-form4_1778014276.xml · nonDerivative · entry 2 Bhatia Sangeeta N. · CIK 0001643921 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,924 F2 · kind: Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1, which was entered into on 05/27/2025. Read SEC document |
| May 01, 2026 Filed May 5, 2026 20:51 UTC |
Bhatia Sangeeta N.Director
|
GrantCommon Stock | 943 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-26-000175 · wk-form4_1778014276.xml · nonDerivative · entry 1 Bhatia Sangeeta N. · CIK 0001643921 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,242 F1 · shares: Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date. Read SEC document |
| May 01, 2026 Filed May 5, 2026 20:54 UTC |
CARNEY LLOYDDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,866 | $0.00 Strike: $424.45 | $0.00 |
DisclosureSEC source: 0000875320-26-000177 · wk-form4_1778014467.xml · derivative · entry 1 CARNEY LLOYD · CIK 0001204424 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,866 Underlying: Common Stock · 2,866 shares Expires 2036-04-30 F1 · derivative.exercise_date: Fully vested. Read SEC document |
| May 01, 2026 Filed May 5, 2026 20:58 UTC |
Garber Alan MDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,433 | $0.00 Strike: $424.45 | $0.00 |
DisclosureSEC source: 0000875320-26-000179 · wk-form4_1778014724.xml · derivative · entry 2 Garber Alan M · CIK 0001312907 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,433 Underlying: Common Stock · 1,433 shares Expires 2036-04-30 F2 · derivative.exercise_date: Fully vested. Read SEC document |
| May 01, 2026 Filed May 5, 2026 20:58 UTC |
Garber Alan MDirector
|
GrantCommon Stock | 472 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-26-000179 · wk-form4_1778014724.xml · nonDerivative · entry 1 Garber Alan M · CIK 0001312907 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,344 F1 · shares: Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date. Read SEC document |
| May 01, 2026 Filed May 5, 2026 21:06 UTC |
Lagarde MichelDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,866 | $0.00 Strike: $424.45 | $0.00 |
DisclosureSEC source: 0000875320-26-000181 · wk-form4_1778015211.xml · derivative · entry 1 Lagarde Michel · CIK 0001518973 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,866 Underlying: Common Stock · 2,866 shares Expires 2036-04-30 F1 · derivative.exercise_date: Fully vested. Read SEC document |
| May 01, 2026 Filed May 5, 2026 21:11 UTC |
Liu JoyEVP and Chief Legal Officer
|
SaleCommon Stock | 1,104 | $425.02 | $469,222.08 |
DisclosureSEC source: 0000875320-26-000183 · wk-form4_1778015480.xml · nonDerivative · entry 1 Liu Joy · CIK 0001847529 · EVP and Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,729 F1 · kind: Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025. Read SEC document |
| May 01, 2026 Filed May 5, 2026 21:18 UTC |
MCKENZIE DIANADirector
|
GrantDeferred Stock Units · Derivative | 796 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000875320-26-000185 · wk-form4_1778015893.xml · derivative · entry 4 MCKENZIE DIANA · CIK 0001754648 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,787.483 Underlying: Common Stock · 796 shares Expires not disclosed F3 · derivative.exercise_price: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death. F2 · price: Upon the vesting of restricted stock units granted to Ms. McKenzie on May 1, 2025, Ms. McKenzie deferred the receipt of 796 shares of common stock and received instead 796 deferred stock units pursuant to our deferred compensation plan. As a result, Ms. McKenzie is reporting the disposition of 796 shares of common stock in exchange for an equal number of deferred stock units. F3 · derivative.exercise_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death. F3 · derivative.expiration_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death. Read SEC document |
| May 01, 2026 Filed May 5, 2026 21:18 UTC |
MCKENZIE DIANADirector
|
Disposition to issuerCommon Stock | 796 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000875320-26-000185 · wk-form4_1778015893.xml · nonDerivative · entry 2 MCKENZIE DIANA · CIK 0001754648 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,378 F2 · price: Upon the vesting of restricted stock units granted to Ms. McKenzie on May 1, 2025, Ms. McKenzie deferred the receipt of 796 shares of common stock and received instead 796 deferred stock units pursuant to our deferred compensation plan. As a result, Ms. McKenzie is reporting the disposition of 796 shares of common stock in exchange for an equal number of deferred stock units. Read SEC document |
| May 01, 2026 Filed May 5, 2026 21:18 UTC |
MCKENZIE DIANADirector
|
GrantCommon Stock | 943 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-26-000185 · wk-form4_1778015893.xml · nonDerivative · entry 1 MCKENZIE DIANA · CIK 0001754648 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,174 F1 · shares: Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date. Read SEC document |
| May 01, 2026 Filed May 5, 2026 21:24 UTC |
SACHS BRUCE IDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,866 | $0.00 Strike: $424.45 | $0.00 |
DisclosureSEC source: 0000875320-26-000187 · wk-form4_1778016282.xml · derivative · entry 1 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,866 Underlying: Common Stock · 2,866 shares Expires 2036-04-30 F1 · derivative.exercise_date: Fully vested. Read SEC document |
| May 01, 2026 Filed May 5, 2026 21:29 UTC |
Schneider JenniferDirector
|
GrantDeferred Stock Units · Derivative | 796 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000875320-26-000189 · wk-form4_1778016579.xml · derivative · entry 4 Schneider Jennifer · CIK 0001783060 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 796 Underlying: Common Stock · 796 shares Expires not disclosed F4 · derivative.exercise_price: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Schneider's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Schneider's disability or death. F2 · price: Upon the vesting of restricted stock units granted to Dr. Schneider on May 1, 2025, Dr. Schneider deferred the receipt of 796 shares of common stock and received instead 796 deferred stock units pursuant to our deferred compensation plan. As a result, Dr. Schneider is reporting the disposition of 796 shares of common stock in exchange for an equal number of deferred stock units. F4 · derivative.exercise_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Schneider's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Schneider's disability or death. F4 · derivative.expiration_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Schneider's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Schneider's disability or death. Read SEC document |
| May 01, 2026 Filed May 5, 2026 21:29 UTC |
Schneider JenniferDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,433 | $0.00 Strike: $424.45 | $0.00 |
DisclosureSEC source: 0000875320-26-000189 · wk-form4_1778016579.xml · derivative · entry 3 Schneider Jennifer · CIK 0001783060 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,433 Underlying: Common Stock · 1,433 shares Expires 2036-04-30 F3 · derivative.exercise_date: Fully vested. Read SEC document |
| May 01, 2026 Filed May 5, 2026 21:29 UTC |
Schneider JenniferDirector
|
Disposition to issuerCommon Stock | 796 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000875320-26-000189 · wk-form4_1778016579.xml · nonDerivative · entry 2 Schneider Jennifer · CIK 0001783060 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,394 F2 · price: Upon the vesting of restricted stock units granted to Dr. Schneider on May 1, 2025, Dr. Schneider deferred the receipt of 796 shares of common stock and received instead 796 deferred stock units pursuant to our deferred compensation plan. As a result, Dr. Schneider is reporting the disposition of 796 shares of common stock in exchange for an equal number of deferred stock units. Read SEC document |
| May 01, 2026 Filed May 5, 2026 21:29 UTC |
Schneider JenniferDirector
|
GrantCommon Stock | 472 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-26-000189 · wk-form4_1778016579.xml · nonDerivative · entry 1 Schneider Jennifer · CIK 0001783060 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,190 F1 · shares: Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date. Read SEC document |
| May 01, 2026 Filed May 5, 2026 21:37 UTC |
Thornberry NancyDirector
|
GrantDeferred Stock Units · Derivative | 398 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000875320-26-000191 · wk-form4_1778017046.xml · derivative · entry 4 Thornberry Nancy · CIK 0001797826 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 398 Underlying: Common Stock · 398 shares Expires not disclosed F4 · derivative.exercise_price: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. Thornberry's service on our board of directors, (ii) a change of control of our company and (iii) Ms. Thornberry's disability or death. F2 · price: Upon the vesting of restricted stock units granted to Ms. Thornberry on May 1, 2025, Ms. Thornberry deferred the receipt of 398 shares of common stock and received instead 398 deferred stock units pursuant to our deferred compensation plan. As a result, Ms. Thornberry is reporting the disposition of 398 shares of common stock in exchange for an equal number of deferred stock units. F4 · derivative.exercise_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. Thornberry's service on our board of directors, (ii) a change of control of our company and (iii) Ms. Thornberry's disability or death. F4 · derivative.expiration_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. Thornberry's service on our board of directors, (ii) a change of control of our company and (iii) Ms. Thornberry's disability or death. Read SEC document |
| May 01, 2026 Filed May 5, 2026 21:37 UTC |
Thornberry NancyDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,433 | $0.00 Strike: $424.45 | $0.00 |
DisclosureSEC source: 0000875320-26-000191 · wk-form4_1778017046.xml · derivative · entry 3 Thornberry Nancy · CIK 0001797826 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,433 Underlying: Common Stock · 1,433 shares Expires 2036-04-30 F3 · derivative.exercise_date: Fully vested. Read SEC document |
| May 01, 2026 Filed May 5, 2026 21:37 UTC |
Thornberry NancyDirector
|
Disposition to issuerCommon Stock | 398 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000875320-26-000191 · wk-form4_1778017046.xml · nonDerivative · entry 2 Thornberry Nancy · CIK 0001797826 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,109 F2 · price: Upon the vesting of restricted stock units granted to Ms. Thornberry on May 1, 2025, Ms. Thornberry deferred the receipt of 398 shares of common stock and received instead 398 deferred stock units pursuant to our deferred compensation plan. As a result, Ms. Thornberry is reporting the disposition of 398 shares of common stock in exchange for an equal number of deferred stock units. Read SEC document |
| May 01, 2026 Filed May 5, 2026 21:37 UTC |
Thornberry NancyDirector
|
GrantCommon Stock | 472 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-26-000191 · wk-form4_1778017046.xml · nonDerivative · entry 1 Thornberry Nancy · CIK 0001797826 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,507 F1 · shares: Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date. Read SEC document |
| May 01, 2026 Filed May 5, 2026 21:44 UTC |
Upadhyay SuketuDirector
|
GrantDeferred Stock Units · Derivative | 796 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000875320-26-000193 · wk-form4_1778017445.xml · derivative · entry 3 Upadhyay Suketu · CIK 0001533149 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,595.156 Underlying: Common Stock · 796 shares Expires not disclosed F3 · derivative.exercise_price: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Upadhyay's service on our board of directors, (ii) a change of control of our company and (iii) Mr. Upadhyay's disability or death. F1 · price: Upon the vesting of restricted stock units granted to Mr. Upadhyay on May 1, 2025, Mr. Upadhyay deferred the receipt of 796 shares of common stock and received instead 796 deferred stock units pursuant to our deferred compensation plan. As a result, Mr. Upadhyay is reporting the disposition of 796 shares of common stock in exchange for an equal number of deferred stock units. F3 · derivative.exercise_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Upadhyay's service on our board of directors, (ii) a change of control of our company and (iii) Mr. Upadhyay's disability or death. F3 · derivative.expiration_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Upadhyay's service on our board of directors, (ii) a change of control of our company and (iii) Mr. Upadhyay's disability or death. Read SEC document |
| May 01, 2026 Filed May 5, 2026 21:44 UTC |
Upadhyay SuketuDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,866 | $0.00 Strike: $424.45 | $0.00 |
DisclosureSEC source: 0000875320-26-000193 · wk-form4_1778017445.xml · derivative · entry 2 Upadhyay Suketu · CIK 0001533149 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,866 Underlying: Common Stock · 2,866 shares Expires 2036-04-30 F2 · derivative.exercise_date: Fully vested. Read SEC document |
| May 01, 2026 Filed May 5, 2026 21:44 UTC |
Upadhyay SuketuDirector
|
Disposition to issuerCommon Stock | 796 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000875320-26-000193 · wk-form4_1778017445.xml · nonDerivative · entry 1 Upadhyay Suketu · CIK 0001533149 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,558 F1 · price: Upon the vesting of restricted stock units granted to Mr. Upadhyay on May 1, 2025, Mr. Upadhyay deferred the receipt of 796 shares of common stock and received instead 796 deferred stock units pursuant to our deferred compensation plan. As a result, Mr. Upadhyay is reporting the disposition of 796 shares of common stock in exchange for an equal number of deferred stock units. Read SEC document |
| April 15, 2026 Filed Apr 17, 2026 20:14 UTC |
Garber Alan MDirector
|
GrantDeferred Stock Units · Derivative | 33.898 | $442.50 | $14,999.87 |
DisclosureSEC source: 0000875320-26-000159 · wk-form4_1776456893.xml · derivative · entry 1 Garber Alan M · CIK 0001312907 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33.898 Underlying: Common Stock · 33.898 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Garber's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Garber's disability or death. F1 · derivative.exercise_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Garber's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Garber's disability or death. F1 · derivative.expiration_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Garber's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Garber's disability or death. Read SEC document |
| April 15, 2026 Filed Apr 17, 2026 20:17 UTC |
SACHS BRUCE IDirector
|
GrantDeferred Stock Units · Derivative | 107.345 | $442.50 | $47,500.16 |
DisclosureSEC source: 0000875320-26-000161 · wk-form4_1776457052.xml · derivative · entry 1 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,671.866 Underlying: Common Stock · 107.345 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death. F1 · derivative.exercise_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death. F1 · derivative.expiration_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death. Read SEC document |
| April 15, 2026 Filed Apr 17, 2026 20:20 UTC |
Upadhyay SuketuDirector
|
GrantDeferred Stock Units · Derivative | 80.508 | $442.50 | $35,624.79 |
DisclosureSEC source: 0000875320-26-000163 · wk-form4_1776457233.xml · derivative · entry 1 Upadhyay Suketu · CIK 0001533149 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,799.156 Underlying: Common Stock · 80.508 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Upadhyay's service on our board of directors, (ii) a change of control of our company and (iii) Mr. Upadhyay's disability or death. F1 · derivative.exercise_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Upadhyay's service on our board of directors, (ii) a change of control of our company and (iii) Mr. Upadhyay's disability or death. F1 · derivative.expiration_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Upadhyay's service on our board of directors, (ii) a change of control of our company and (iii) Mr. Upadhyay's disability or death. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:53 UTC |
Liu JoyEVP and Chief Legal Officer
|
SaleCommon Stock | 978 | $449.17 | $439,288.26 |
DisclosureSEC source: 0000875320-26-000157 · wk-form4_1775249628.xml · nonDerivative · entry 1 Liu Joy · CIK 0001847529 · EVP and Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,833 F1 · kind: Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025. Read SEC document |
| March 27, 2026 Filed Mar 31, 2026 20:10 UTC |
Bozic CarmenEVP and CMO
|
SaleCommon Stock | 2,329 | $450.95 | $1,050,262.55 |
DisclosureSEC source: 0000875320-26-000149 · wk-form4_1774987818.xml · nonDerivative · entry 1 Bozic Carmen · CIK 0001790029 · EVP and CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,076 F1 · kind: Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025. Read SEC document |
| March 13, 2026 Filed Mar 17, 2026 20:04 UTC |
Bozic CarmenEVP and CMO
|
SaleCommon Stock | 2,329 | $481.79 | $1,122,088.91 |
DisclosureSEC source: 0000875320-26-000140 · wk-form4_1773777858.xml · nonDerivative · entry 1 Bozic Carmen · CIK 0001790029 · EVP and CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,405 F1 · kind: Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 20:11 UTC |
McKechnie DuncanEVP, Chief Commercial Officer
|
SaleCommon Stock | 2,633 | $498.42 | $1,312,339.86 |
DisclosureSEC source: 0000875320-26-000138 · wk-form4_1773432707.xml · nonDerivative · entry 1 McKechnie Duncan · CIK 0002062139 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,489 F1 · kind: Transaction made pursuant to Mr. McKechnie's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:05 UTC |
McKechnie DuncanEVP, Chief Commercial Officer
|
SaleCommon Stock | 2,437 | $475.30 | $1,158,306.10 |
DisclosureSEC source: 0000875320-26-000136 · wk-form4_1772831152.xml · nonDerivative · entry 1 McKechnie Duncan · CIK 0002062139 · EVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,122 F1 · kind: Transaction made pursuant to Mr. McKechnie's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:21 UTC |
Liu JoyEVP and Chief Legal Officer
|
SaleCommon Stock | 892 | $495.96 | $442,396.32 |
DisclosureSEC source: 0000875320-26-000134 · wk-form4_1772659274.xml · nonDerivative · entry 1 Liu Joy · CIK 0001847529 · EVP and Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,811 F1 · kind: Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.